LAVAL, Quebec, Sept. 10, 2012 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (" Neptune") (Nasdaq:NEPT) (TSX:NTB) announced on September 7, 2012 that its board of directors has approved the distribution of 2,000,000 units (each a " Unit") of NeuroBioPharm Inc. (" NeuroBio") owned by Neptune pro rata to the holders of record of common shares of Neptune (the " Shareholders") as at October 15, 2012 (the " Dividend Record Date") by way of a dividend-in-kind (the " Dividend"). The Dividend will be payable on October 31, 2012.
REPEAT: Neptune Announces Dividend-in-Kind And Record Date For Partial Spin-Off Of NeuroBioPharm Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.